PHILIP VITALE, M.D.

Corporate Board Profile

Tech Score: 0/100

Perspective Therapeutics, Inc.

Filing Date	Source Excerpt
2017-05-17	Philip Vitale MD Fees earned or paid in cash: $44,000 Option awards: $16,400 Total: $16,400 The Compensation Committee of the Board of Directors has reviewed and discussed the matters contained under the title Compensation Discussion and Analysis of this Proxy Statement with our management and, based on such review and discussions we recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement on Schedule 14A for the Company’s fiscal year ended June 30, 2016. Respectfully submitted, Philip Vitale, MD (Chair) Alan Hoffmann Michael McCormick

Filing Date

Source Excerpt

2017-05-17

Philip Vitale MD Fees earned or paid in cash: $44,000 Option awards: $16,400 Total: $16,400 The Compensation Committee of the Board of Directors has reviewed and discussed the matters contained under the title Compensation Discussion and Analysis of this Proxy Statement with our management and, based on such review and discussions we recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement on Schedule 14A for the Company’s fiscal year ended June 30, 2016. Respectfully submitted, Philip Vitale, MD (Chair) Alan Hoffmann Michael McCormick

Data sourced from SEC filings. Last updated: 2025-10-11